No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Leukoencephalopathy, Progressive Multifocal / chemically induced*
-
Leukoencephalopathy, Progressive Multifocal / diagnosis
-
Leukoencephalopathy, Progressive Multifocal / etiology
-
Lymphoma, Follicular / complications*
-
Lymphoma, Follicular / diagnosis
-
Lymphoma, Follicular / virology
-
Male
-
Middle Aged
-
Opportunistic Infections / diagnosis
-
Opportunistic Infections / etiology
-
Time Factors
-
Vidarabine / administration & dosage
-
Vidarabine / adverse effects*
-
Vidarabine / analogs & derivatives*
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Vidarabine
-
fludarabine